Completed Studies – Adenoid Cystic Carcinoma Research Foundation
No chemotherapies, immunotherapies or targeted drugs are approved by regulatory authorities for ACC because none have demonstrated yet the ability to shrink tumors significantly or extend lives in a large proportion of ACC patients.
Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Related signals
- Correction: Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features
- A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug
- Deciphering the potential pathogeny of rare tracheal adenoid cystic carcinoma by single‑cell RNA‑sequencing
- Adenoid cystic carcinoma (ACC)
- DAY301 | Day One Biopharmaceuticals